Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 1;33(1):1-16.
doi: 10.7555/JBR.31.20160164. Online ahead of print.

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes

Affiliations

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes

Toru Hiyoshi et al. J Biomed Res. .

Abstract

Postprandial glucose level is an independent risk factor for cardiovascular disease that exerts effects greater than glucose levels at fasting state, whereas increase in serum triglyceride level, under both fasting and postprandial conditions, contributes to the development of arteriosclerosis. Insulin resistance is a prevailing cause of abnormalities in postabsorptive excursion of blood glucose and postprandial lipid profile. Excess fat deposition renders a vicious cycle of hyperglycemia and hypertriglyceridemia in the postprandial state, and both of which are contributors to atherosclerotic change of vessels especially in patients with type 2 diabetes mellitus. Several therapeutic approaches for ameliorating each of these abnormalities have been attempted, including various antidiabetic agents or new compounds targeting lipid metabolism.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Blood glucose and lipid regulation. pancreas, liver and blood vessels. After meal, pancreatic beta cells release insulin to inhibit hepatic gluconeogenesis and glycogenolysis. Insulin also acts at peripheral tissues to increase glucose uptake (muscle), contributing to decreased blood glucose level. GLP-1 and GIP are incretin hormones which secreted by the gut. Incretin hormones can stimulate pancreatic beta cells to secrete insulin. GLP-1 suppressed inappropriate glucagon secretion from pancreatic alpha cells. Nutrient from the gastrointestinal tract, muscle and adipose tissue such as glucose, amino acids and glycerol which are energy resource of the body introduce into the liver. In insulin resistance state, overproduction of TRL associated with hepatic VLDL production. Increasing TRL is strongly contribute hypertryglyceridemia which is related indirectly to atherosclerotic progression through increase in sdLDL and lowered HDL. Interaction between enlarged fat cell and macrophages in adipose tissue evokes chronic inflammatory response, resulting in overproduction of FFA.
Fig.2
Fig.2
Vascular injury due to glucose spike in T2D. The rapid fluctuation in blood glucose level repeated every meal is called "glucose spike", which damages blood vessels and causes progression of atherosclerosis. In this condition, increasing lipid peroxydation, platelet coagulation and synthesis of ROS. Arteriosclerosis starts from the early stage of postprandial hyperglycemia of diabetes, or the stage of IGT earlier than that.

References

    1. Group TDS, and the The DECODE Study Group. Group on behalf of the EDE. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?[J] Diabetes Care, 2003, 26(3): 688–696 10.2337/diacare.26.3.688. - DOI - PubMed
    1. Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease[J]? Arch Intern Med, 2004, 164(19): 2147–2155 10.1001/archinte.164.19.2147. - DOI - PubMed
    1. DECODE Study Group, and the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria[J]. Arch Intern Med, 2001, 161(3): 397–405 10.1001/archinte.161.3.397. - DOI - PubMed
    1. Sone H, Tanaka S, Tanaka S, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: Subanalysis of the Japan Diabetes Complications Study (JDCS)[J]. J Clin Endocrinol Metab, 2011, 96(11): 3448–3456 10.1210/jc.2011-0622. - DOI - PubMed
    1. Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial[J]. Lancet, 2006, 368(9452): 1155–1163 10.1016/S0140-6736(06)69472-5. - DOI - PubMed

LinkOut - more resources